Cargando…

M212. A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL VARIABLES ASSOCIATED WITH RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA

BACKGROUND: Approximately one third of patients with schizophrenia display suboptimal response to two trials of non-clozapine antipsychotic medication and may be termed treatment resistant. Clozapine is the only licensed pharmacotherapy for treatment resistant schizophrenia, but response to clozapin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griffiths, Kira, MacCabe, James, Egerton, Alice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session II
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234583/ http://dx.doi.org/10.1093/schbul/sbaa030.524

Ejemplares similares

T19. GLUTAMATE AND RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Egerton, Alice, et al.
Publicado: (2020)

M215. FACTORS ASSOCIATED WITH CLOZAPINE RESPONSE AND RESISTANCE IN SCHIZOPHRENIA
por: Lee, Jimmy, et al.
Publicado: (2020)

M202. SEX-RELATED DIFFERENCES IN CLOZAPINE SIDE EFFECTS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA
por: Martini, Francesca, et al.
Publicado: (2020)

M60. EARLY VERSUS DELAYED PRESCRIPTION OF CLOZAPINE AND THE COGNITIVE PERFORMANCE ON SCHIZOPHRENIA
por: Amoretti, Silvia, et al.
Publicado: (2020)

M40. ECT VERSUS SHAM FOR CLOZAPINE RESISTANT SCHIZOPHRENIA: A SECONDARY ANALYSIS OF A PILOT STUDY BASED ON PANSS-30 FACTOR ANALYTIC DIMENSIONS AND THE PANSS-6
por: Luciana Melzer-Ribeiro, Debora, et al.
Publicado: (2020)

M204. ULTRA-RESISTANT SCHIZOPHRENIA IS ASSOCIATED WITH A DELAY TO INITIATE CLOZAPINE AND WITH LESS ABDOMINAL OBESITY. SEX DIFFERENCES IN INSULINEMIA AND LEPTIN LEVELS ARE OBSERVED BETWEEN RESPONDERS AND NOT RESPONDERS
por: Hönig, Guillermo, et al.
Publicado: (2020)

M200. CLOZAPINE-INDUCED HEPATOTOXICITY: TWO CASE REPORTS
por: Dias, Cintia, et al.
Publicado: (2020)

S146. EFFECT OF CLOZAPINE ON REGIONAL CEREBRAL BLOOD FLOW IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Sendt, Kyra-Verena, et al.
Publicado: (2018)

M138. THE STRUCTURAL AND FUNCTIONAL BRAIN IMPACT OF CLOZAPINE IN SCHIZOPHRENIC PATIENTS: REVIEW OF THE LITERATURE
por: Metivier, Lucie, et al.
Publicado: (2020)

M188. PSYCHOSOCIAL INTERVENTIONS FOR RELAPSE PREVENTION IN SCHIZOPHRENIA: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Publicado: (2020)

S62. COGNITIVE DEFICITS IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Millgate, Edward, et al.
Publicado: (2020)

M46. THE STUDY OF HEART RATE VARIABILITY AND EMOTIONAL RESPONSE TO POSITIVE AND NEGATIVE AUDIOVISUAL STIMULATION IN PATIENTS WITH SCHIZOPHRENIA
por: Jang, Seung-Ho, et al.
Publicado: (2020)

M89. PHARMACOLOGICAL INTERVENTIONS FOR SMOKING CESSATION AMONG PEOPLE WITH SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Siskind, Dan, et al.
Publicado: (2020)

M88. EVIDENCE FOR INFLAMMATION AS A PUTATIVE SHARED MECHANISM FOR INSULIN RESISTANCE AND SCHIZOPHRENIA
por: Perry, Benjamin, et al.
Publicado: (2020)

M184. SOCIAL SKILLS TRAINING FOR TREATMENT-RESISTANT SCHIZOPHRENIA WITH PREDOMINANTLY NEGATIVE SYMPTOMS
por: Kayo, Monica, et al.
Publicado: (2020)

M157. A MULTICENTRE STUDY OF 1H-MRS BRAIN GLUTAMATE LEVELS IN SCHIZOPHRENIA; INVESTIGATING THE EFFECT OF ANTIPSYCHOTIC MEDICATION, SYMPTOM SEVERITY AND AGE
por: Merritt, Kate, et al.
Publicado: (2020)

M39. AN UPDATE ON THE EFFICACY OF ANTI-INFLAMMATORY AGENTS FOR PATIENTS WITH SCHIZOPHRENIA: A META-ANALYSIS
Publicado: (2020)

M201. MODERATORS OF WEIGHT GAIN IN RANDOMIZED CONTROLLED TRIALS OF SCHIZOPHRENIA – A META-REGRESSION ANALYSIS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2020)

M248. VOICE PATTERNS IN SCHIZOPHRENIA: A CROSS-LINGUISTIC REPLICATION OF PREVIOUS META-ANALYTIC FINDINGS
por: Parola, Alberto, et al.
Publicado: (2020)

M49. BEHAVIOURAL SOCIAL COGNITION IN SCHIZOPHRENIA SPECTRUM DISORDERS IN COMPARISON TO AUTISM SPECTRUM DISORDER: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Oliver, Lindsay, et al.
Publicado: (2020)

M73. DRIVING ABILITIES IN PATIENTS WITH SCHIZOPHRENIA
por: Pardeller, Silvia, et al.
Publicado: (2020)

M190. USE OF NULL PRONOUNS IN SCHIZOPHRENIA
por: Chaves, Monica, et al.
Publicado: (2020)

M168. CLINICAL-ANATOMICAL PHENOTYPES OF SCHIZOPHRENIA
por: Kirschner, Matthias, et al.
Publicado: (2020)

M109. WEIGHT GAIN AND THE PATHOPHYSIOLOGY OF SCHIZOPHRENIA
Publicado: (2020)

M149. THE TOPOGRAPHY OF STRIATAL DOPAMINE AND SYMPTOMS IN PSYCHOSIS: AN INTEGRATIVE PET AND MRI STUDY
por: McCutcheon, Rob, et al.
Publicado: (2020)

M64. ADDRESSING THE ROLE OF TIMING ON COGNITION IN SCHIZOPHRENIA
por: Alústiza, Irene, et al.
Publicado: (2020)

M117. ELUCIDATING ARCHITECTURE OF NEGATIVE SYNDROME IN SCHIZOPHRENIA
por: San Ang, Mei, et al.
Publicado: (2020)

M245. AN RCT PROTOCOL OF HYBRID-ECT FOR SCHIZOPHRENIA
por: Rong, Han
Publicado: (2020)

M198. INVESTIGATIONAL DOPAMINE ANTAGONISTS FOR THE TREATMENT OF SCHIZOPHRENIA
Publicado: (2020)

41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018)

M23. ALTERATION OF REGIONAL CEREBRAL BLOOD FLOW MEASURED BY ARTERIAL SPIN LABELING IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA
por: Ogyu, Kamiyu, et al.
Publicado: (2020)

M222. SURVEY RESULTS FROM TURKEY: KNOWLEDGE ABOUT SCHIZOPHRENIA, PUBLIC STIGMA AND DISCRIMINATION BECAUSE OF SCHIZOPHRENIA
por: Haldun, Soygur, et al.
Publicado: (2020)

M106. VIRTUAL-REALITY COGNITIVE TRAINING AND ASSESSMENT IN SCHIZOPHRENIA
por: Porffy, Lilla, et al.
Publicado: (2020)

M55. STRUCTURAL CHANGES RELEVANT TO MUSICAL DEFICITS IN SCHIZOPHRENIA
por: Sawada, Ken, et al.
Publicado: (2020)

M228. THE EFFECT OF SOCIALIZATION ON ANTICIPATORY AND CONSUMMATORY PLEASURE IN SCHIZOPHRENIA
por: Merchant, Jaisal, et al.
Publicado: (2020)

M161. NEURAL CHANGES INDUCED BY ELECTROCONVULSIVE THERAPY (ECT) IN SCHIZOPHRENIA PATIENTS: A SYSTEMATIC REVIEW
por: Moon, Sun-Young, et al.
Publicado: (2020)

M67. UNDERSTANDING SOCIAL COGNITION IN SCHIZOPHRENIA THROUGH THE LENS OF SCHIZOTYPY
por: Lee, Sara-Ann, et al.
Publicado: (2020)

M41. TRAJECTORIES AND PREDICTORS OF OUTCOME IN SCHIZOPHRENIA: THE BENEFICIAL ROLE OF AMISULPRIDE
por: Drosos, Petros, et al.
Publicado: (2020)

M243. EFFECTIVENESS AND SATISFACTION WITH A SCHIZOPHRENIA RECOVERY DAY PROGRAM
por: Murata, Lisa, et al.
Publicado: (2020)

M13. INCREASED SAFETY SEEKING IN PATIENTS WITH SCHIZOPHRENIA AND PARANOID THREAT
por: Gangl, Nicole, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j9be6bmotsrvn4nls5o9i3rdb2